Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
AstraZeneca
Accenture
Harvard Business School
Healthtrust
Daiichi Sankyo
Moodys
Baxter
Chinese Patent Office
Medtronic

Generated: December 11, 2017

DrugPatentWatch Database Preview

BROMOCRIPTINE MESYLATE Drug Profile

« Back to Dashboard

When do Bromocriptine Mesylate patents expire, and when can generic versions of Bromocriptine Mesylate launch?

Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.

The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
Drug patent expirations by year for BROMOCRIPTINE MESYLATE

Pharmacology for BROMOCRIPTINE MESYLATE

Ingredient-typeErgolines
Drug ClassErgot Derivative

Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Lek PharmBROMOCRIPTINE MESYLATEbromocriptine mesylateCAPSULE;ORAL075100-001Dec 10, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanBROMOCRIPTINE MESYLATEbromocriptine mesylateTABLET;ORAL076962-001Sep 24, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanBROMOCRIPTINE MESYLATEbromocriptine mesylateCAPSULE;ORAL077226-001Apr 4, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncBROMOCRIPTINE MESYLATEbromocriptine mesylateCAPSULE;ORAL078899-001Jul 30, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncBROMOCRIPTINE MESYLATEbromocriptine mesylateTABLET;ORAL074631-001Jan 13, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Paddock LlcBROMOCRIPTINE MESYLATEbromocriptine mesylateTABLET;ORAL077646-001Oct 1, 2008ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Deloitte
Chubb
Express Scripts
Medtronic
Covington
Fish and Richardson
Mallinckrodt
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot